Division of Otolaryngology, Head and Neck Surgery, Department of Surgery, University of California, San Diego, La Jolla, California, USA.
Neurogenomics Division and Center for Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, Arizona, USA.
Ear Hear. 2020 Jul/Aug;41(4):983-989. doi: 10.1097/AUD.0000000000000819.
A small subset of children with congenital hearing loss have abnormal cochleovestibular nerves (i.e., absent, aplastic, or deficient cochlear nerves), with largely unknown etiology. Our objective was to investigate the underlying pathways and identify novel genetic variants responsible for cochleovestibular malformations and nerve abnormalities. It is our hypothesis that several cochleovestibular nerve abnormalities might share common causative pathways.
We used a family-based exome sequencing approach to study 12 children with known rare inner ear and/or cochleovestibular nerve malformations.
Our results highlight a diverse molecular etiology and suggest that genes important in the developing otic vesicle and cranial neural crest, e.g., MASP1, GREB1L, SIX1, TAF1, are likely to underlie inner ear and/or cochleovestibular nerve malformations.
We show that several cochleovestibular nerve malformations are neurocristopathies, which is consistent with the fact that cochleovestibular nerve development is based on otic placode-derived neurons in close association with neural crest-derived glia cells. In addition, we suggest potential genetic markers for more severely affected phenotypes, which may help prognosticate individual cochlear implantation outcomes. Developing better strategies for identifying which children with abnormal nerves will benefit from a cochlear implantation is crucial, as outcomes are usually far less robust and extremely variable in this population, and current neuroimaging and electrophysiologic parameters cannot accurately predict outcomes. Identification of a suitable treatment early will reduce the use of multiple interventions during the time-sensitive period for language development.
一小部分先天性听力损失儿童存在耳蜗前庭神经异常(即缺失、发育不良或耳蜗神经发育不良),其病因很大程度上未知。我们的目的是研究潜在的途径,并确定导致耳蜗前庭畸形和神经异常的新的遗传变异。我们假设几种耳蜗前庭神经异常可能存在共同的致病途径。
我们使用基于家系的外显子组测序方法研究了 12 名已知存在内耳和/或耳蜗前庭神经畸形的儿童。
我们的研究结果强调了一个多样化的分子病因,并表明在发育中的耳囊和颅神经嵴中起重要作用的基因,例如 MASP1、GREB1L、SIX1、TAF1,可能是内耳和/或耳蜗前庭神经畸形的基础。
我们表明,几种耳蜗前庭神经异常是神经嵴病变,这与耳蜗前庭神经发育基于耳囊来源的神经元与神经嵴来源的胶质细胞密切相关的事实一致。此外,我们提出了更严重表型的潜在遗传标志物,这可能有助于预测个体耳蜗植入的结果。开发更好的策略来确定哪些神经异常的儿童将从耳蜗植入中受益至关重要,因为在这个人群中,结果通常远不那么稳健,而且极其多变,目前的神经影像学和电生理参数无法准确预测结果。早期确定合适的治疗方法将减少在语言发育的关键时期内对多种干预措施的使用。